The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Name: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Published: 2024
License: Public Domain

Eli Lilly and Company · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

cardiovascular-disease type-2-diabetes

atherosclerotic cardiovascular disease (ascvd), chronic kidney disease (ckd), cardiovascular disease, kidney disease, major adverse cardiovascular events (mace), renal outcomes, cardiovascular risk reduction, kidney disease progression, cardiometabolic risk factors, cardiovascular outcomes, kidney outcomes, type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1047945
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.